Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Bonnie S Glisson Charles Rudin |
| Publication date | December 2, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |